Stocks
Arcturus Therapeutics Holdings (ARCT) EV/EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -6.07 | -3.35 | 12.6 | -6.91 | -437.5 | -3.61 | ||
| Changes by years, y/y, % | +95% | -45% | -478% | -155% | +6 234% | +245.0% | |||
Arcturus Therapeutics Holdings. EV/EBITDA
Arcturus Therapeutics Holdings. EV/EBITDA, changes, %
Arcturus Therapeutics Holdings (ARCT) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| EV/EBITDA | ? | 24.7 | 11.6 | -4.95 | -5.23 | -6.12 | -3.61 | |
| Changes by years, y/y, % | -1 847% | -781% | -157% | -161% | -188% | |||
| Changes by quarters, q/q, % | +256% | -53% | -143% | +6% | +17% | |||
